RecruitingNCT07065747

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

Objective Grading of Intraocular Inflammation in Uveitis Using Optical Coherence Tomography

Sponsor

Oregon Health and Science University

Enrollment

125 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Sarcoidosis Birdshot Chorioretinitis Behcet Disease Juvenile Idiopathic Arthritis (JIA)Posterior Vitreous Detachment Anterior Uveitis (AU)Herpes Simplex Virus Spondyloarthritis (SA)

Summary

The goal of this study is to determine if it's possible to use a high resolution imaging device called optical coherence tomography (OCT) to develop an unbiased, standard method of counting and categorizing the various types of cells and proteins found in an eye condition called anterior uveitis. Anterior uveitis is a type of inflammation in the eye that can be caused by many different diseases of the body.

Eligibility

Min Age: 5 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with anterior uveitis (au), behcet disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 5 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.